- All > Medicine Access and Rational Use > Antimicrobial Drug Resistance
- All > Medicine Access and Rational Use > Rational Use
- Keywords > action plan
- Keywords > antimicrobial resistance (AMR)
- Keywords > containment of antimicrobial resistance
- Keywords > drug resistance surveillance
- Keywords > drug resistance, microbial
- Keywords > drug-resistant gonococcal infections
- Keywords > gonorrhoea
- Keywords > Neisseria gonorrhoeae
- Keywords > resistance containment
- Keywords > strategies
- Keywords > confinement antimicrobien
(2012; 40 pages)
The emergence and spread of drug-resistant pathogens has accelerated. The trends are clear and ominous. No action today means no cure tomorrow. At a time of multiple calamities in the world, we cannot allow the loss of essential medicines – essential cures for many millions of people – to become the next global crisis. Statement of WHO Director-General, Margaret Chan on World Health Day 2011.
Gonorrhoea is a major public health challenge today, due to the high incidence of infections accompanied by a dwindling of treatment options. The objective of this global action plan is to control the spread and minimize the impact of antimicrobial resistance (AMR) in Neisseria gonorrhoeae (N. gonorrhoeae). This document is targeted at a number of stakeholders including national- and international-level policy-makers, programme managers, health-care providers, laboratory technicians, multilateral organizations, researchers and donors.
The document aims to give guidance on ways to contain the spread of AMR in N. gonorrhoeae and it is designed to be implemented in conjunction with broader national and international strategies for the prevention and control of sexually transmitted infections (STIs).